MONTREAL, CANADA -- (MARKET WIRE) -- December 22, 2006 -- ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, today announced the extension of its current agreement with GE Healthcare ("GEHC" or "GE") for the exclusive worldwide distribution of its eXplore Optix™ preclinical optical molecular imaging system.
